The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases - PubMed (original) (raw)
Review
The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases
Christopher A Ross et al. Trends Cell Biol. 2004 Dec.
Abstract
During the past decade, it has become apparent that a set of ostensibly unrelated neurodegenerative diseases, including Parkinson's disease and Huntington's disease, shares striking molecular and cell biology commonalities. Each of the diseases involves protein misfolding and aggregation, resulting in inclusion bodies and other aggregates within cells. These aggregates often contain ubiquitin, which is the signal for proteolysis by the 26S proteasome, and chaperone proteins that are involved in the refolding of misfolded proteins. The link between the ubiquitin-proteasome system and neurodegeneration has been strengthened by the identification of disease-causing mutations in genes coding for several ubiquitin-proteasome pathway proteins in Parkinson's disease. However, the exact molecular connections between these systems and pathogenesis remain uncertain and controversial. In this article, we summarize the state of current knowledge, focusing on important unresolved questions.
Similar articles
- A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G, Schlüter OM, Südhof TC. Gallardo G, et al. Nat Neurosci. 2008 Mar;11(3):301-8. doi: 10.1038/nn2058. Epub 2008 Feb 24. Nat Neurosci. 2008. PMID: 18297066 - Ubiquitin-proteasome system and Parkinson's disease.
Olanow CW, McNaught KS. Olanow CW, et al. Mov Disord. 2006 Nov;21(11):1806-23. doi: 10.1002/mds.21013. Mov Disord. 2006. PMID: 16972273 Review. - The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM, van Leeuwen FW, Fischer DF. Hol EM, et al. Trends Mol Med. 2005 Nov;11(11):488-95. doi: 10.1016/j.molmed.2005.09.001. Epub 2005 Oct 6. Trends Mol Med. 2005. PMID: 16213790 Review. - Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM, Fischer DF, Ovaa H, Scheper W. Hol EM, et al. Expert Rev Neurother. 2006 Sep;6(9):1337-47. doi: 10.1586/14737175.6.9.1337. Expert Rev Neurother. 2006. PMID: 17009921 Review.
Cited by
- How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.
Bethea CL, Reddy AP, Christian FL. Bethea CL, et al. J Alzheimers Dis. 2017;57(4):1001-1015. doi: 10.3233/JAD-160601. J Alzheimers Dis. 2017. PMID: 27662311 Free PMC article. Review. - Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.
Ragland M, Hutter C, Zabetian C, Edwards K. Ragland M, et al. Am J Epidemiol. 2009 Dec 1;170(11):1344-57. doi: 10.1093/aje/kwp288. Epub 2009 Oct 28. Am J Epidemiol. 2009. PMID: 19864305 Free PMC article. Review. - Processing of optineurin in neuronal cells.
Shen X, Ying H, Qiu Y, Park JS, Shyam R, Chi ZL, Iwata T, Yue BY. Shen X, et al. J Biol Chem. 2011 Feb 4;286(5):3618-29. doi: 10.1074/jbc.M110.175810. Epub 2010 Nov 8. J Biol Chem. 2011. PMID: 21059646 Free PMC article. - Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy.
Ramser J, Ahearn ME, Lenski C, Yariz KO, Hellebrand H, von Rhein M, Clark RD, Schmutzler RK, Lichtner P, Hoffman EP, Meindl A, Baumbach-Reardon L. Ramser J, et al. Am J Hum Genet. 2008 Jan;82(1):188-93. doi: 10.1016/j.ajhg.2007.09.009. Am J Hum Genet. 2008. PMID: 18179898 Free PMC article. - alpha-Synuclein: a therapeutic target for Parkinson's disease?
Maguire-Zeiss KA. Maguire-Zeiss KA. Pharmacol Res. 2008 Nov-Dec;58(5-6):271-80. doi: 10.1016/j.phrs.2008.09.006. Epub 2008 Sep 16. Pharmacol Res. 2008. PMID: 18840530 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous